Dr Camille Guillerey

PhD

ARC DECRA Fellow - Mater Career Track Fellow

My Research

I am interested in blood cancers. These cancers include Lymphoma, Leukemia and Multiple Myeloma. I study how immune cells respond to these cancers and how we can harness this immune response to design better treatments for cancer patients.

Projects

Immune regulation by Natural Killer cells

Honours position - Available 2023

ABOUT THE PROJECT

Our laboratotory is investigating the interactions between two immune cell types: natural killer (NK) cells and dendritic cells (DCs). NK cells play an essential role in the early detection of infections or malignant transformation while DCs initiate and direct immune responses. Evidence for bi-directional interactions between NK cells and DCs has been provided in the early 2000s. Since then, our knowledge of NK cell and DC diversity has considerably increased. NK cells and DCs can no longer be considered as homogenous populations up to 30,000 phenotypic populations identified by mass cytometry in one individual while four main human DC subsets have been described: monocyte-derived DCs, plasmacytoid DCs and type 1 and 2 conventional DCs. Currently, we don’t know which NK subset(s) interact with which DC subset(s).

The Honours project aims to define which NK cell subsets mediate DC activation. The candidate will have access to state-of-the-art technology including high-parameter flow cytometry (BD Fortessa and BD FACSymphony analysers) as well as cutting-edge humanised mouse models. By addressing an important knowledge gap in the field, this project will lay the foundation for preclinical research in a wide range of pathologies including cancer, infectious diseases and autoimmune disorders.

Connect

ORCIDGoogle Scholar